Tactile Systems Technology, Inc. (TCMD) Research
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Market snapshot
- Symbol
- TCMD
- Price
- $26.62
- Day change
- +3.06%
- Market cap
- $600.4M
- P/E ratio
- 29.59x
- 52-week range
- 9.415-37.77
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 1 month
- Analyst price target
- $39.25
Peer companies
Recent insider activity
- Birkemeyer Elaine M. — S-Sale (4631 shares) on 2026-05-11
- Asbury Valerie L. — A-Award (6521 shares) on 2026-05-06
- Huggenberger Raymond — A-Award (6521 shares) on 2026-05-06
- King Laura G. — A-Award (6521 shares) on 2026-05-06
- Pearson Andrea — A-Award (6521 shares) on 2026-05-06
Open Tactile Systems Technology, Inc. (TCMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.